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Within the last few years, the study of anky-
losing spondylitis has produced some of the more 
remarkable new developments in the field of the 
rheumatic diseases. In modern days the disease has 
been described in Germany by Striimpell and in 
France by Marie. As a result, in Germany it is 
known as Striimpell's disease and in France as 
Marie's disease. Physicians in the United States and 
England, to be fair, call it Marie-Striimpell disease. 
It should be emphasized at this point that ankylosing 
spondylitis is not a variant of rheumatoid arthritis 
as it had been considered for a number of years. 
The term rheumatoid spondylitis is still occasionally 
used but should be completely abandoned. 
The initial diagnosis of ankylosing spondylitis 
is often a difficult one to make. The best criteria we 
have are quite simple. They are 1) limitation of 
motion of the lumbar spine; 2) pain in the low back; 
and 3) limitation of chest expansion. As you can 
see, no laboratory tests except the x-ray film are 
used and in the early stages, x-ray film examination 
may not be helpful. 
Examination of the lumbar spine in some studies 
shows that limitation of extension may actually be 
a better way of separating normal from abnormal 
spines ( 1), although limitation of flex ion (flattening 
of the lumbar curve) is usually what we look for 
in the back examination. Moll and Wright (2) have 
shown that lateral spinal flexion is the best way 
to distinguish between spondylitis and lumbar disc 
disease. Spondylitis will also cause limitation in this 
direction. 
The erythrocyte sedimentation rate can be 
normal in patients with ankylosing spondylitis. 
Even patients with rather marked degrees of pain 
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can have normal sedimentation rates while patients 
who may just show changes in the sacroiliac, hips, 
or back without pain can have a significantly elevated 
sedimentation rate. Of course, rheumatoid factor is 
not found in these patients and can be of diagnostic 
help only by its absence. 
The patient with ankylosing spondylitis is 
usually a young white male who gives a fairly 
typical story. Back pain usually wakes him up in 
the small hours of the morning. It is rare that he 
will complain of being unable to go to sleep because 
of pain. He will usually awake because of discom-
fort in the lower back and get out of bed. He may 
get relief (and go back to sleep) lying on the floor 
or sitting up in a hard back chair or sitting on the 
floor with his back against the wall. The pain fre-
quently, as with sciatica, goes down the back of the 
legs. Alternation of the radiating pain from one side 
to the other is a typical feature which helps to 
distinguish the symptoms from those produced by a 
lumbar disc protrusion. 
Examination of the x-ray films may initially 
show erosions in the sacroiliac joints and finally 
fusion, and of course, the "bamboo" spine of late 
disease is well known. The development of the 
changes in the spine can be shown diagrammatically 
so one can differentiate the syndesmophyte of anky-
losing spondylitis from the osteophyte of degenera-
tive joint disease (Fig. 1). This is taken from a 
recent article of Riley, Ansell, and Bywaters (3). 
On the left in the figure is seen the progression of 
osteophytosis and on the right, the progression of 
syndesmophytosis. The osteophyte is associated with 
disc narrowing. The bony plate is marginal and most 
importantly is horizontal as seen in stages three and 
four. It is built up at the base with subperiosteal 
bone. The base appears to lie against protruded 
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disc narrowing or protrusion. A vertical plate is 
built up in the outer layer of the annulus fibrosis. 
These syndesmophytes will ultimately bridge in stage 
IV of the disease. 
Ankylosing spondylitis is a disease of young 
males, seen in Figure 2 where the peak in a large 
series is found to occur in the late teens and early 
20's (4, pg. 10). There is, however, a group of 
ankylosing spondylitics who start at an earlier age. 
Barbara Ansell and Eric Bywaters in Taplow, Eng·· 
land followed up 139 patients with juvenile rheuma-
toid arthritis (JRA), 55 males and 84 females, for 
at least 15 years into adult life. What was striking 
about the 55 males was that 9% of them, as they 
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went on to adulthood, developed typical ankylosing 
spondylitis. 
Joint involvement in ankylosing spondylitis is, 
of course, different from that seen in patients with 
rheumatoid arthritis. Forestier ( 4) showed (Table 
1) the high frequency of hip involvement in this 
disease when compared to patients with rheumatoid 
arthritis. In the rheumatoid, there is much more 
peripheral joint involvement. 
There are a number of complications which 
are more specific and more frequent in ankylosing 
spondylitis than in many of the other forms of 
arthritis . Most of the complications that have been 
noted are listed in Table 2. Iritis is said to occur in 
up to 20% of patients. Aortic insufficiency is usually 
seen quite late in the disease. Heart block is rarely 
seen but also probably represents the same type of 
inflammatory action in the myocardium as is seen 
in the aorta. Amyloidosis, again, is not seen 
frequently but is a recognized cause of death in 
ankylosing spondylitis-certainly more so than with 
rheumatoid arthritis. Atlantoaxial subluxation is a 
constant threat to these people with spine fusion and 
can sometimes be fatal after only moderate degrees 
of trauma. Cauda equina involvement is rarely seen 
but, again, is a well-recognized problem. Pulmonary 
fibrosis of the upper lobe is of interest because this 
fibrosis, which may be typical of spondylitics, has 
been mistaken for tumor, tuberculosis, and the like. 
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TABLE 1 
PERIPHERAL JOINT INVOLVEMENT AT ONSET* 
Ankylosing Rheumatoid 
Spondylitis Arthritis 
(200 patients) (100 patients) 
Joint % % 
Hips 42 10 
Knees 29 62 
Ankles 7 58 
Feet 12 28 
Shoulders 30 64 
Elbows 3 46 
Wrists 5 82 
Hands 7 94 
Temperomandibular 6 8 
Sternoclavicular 11 7 
* After Forestier ( 4) 
It probably accounts for some of the earlier state-
ments made about the higher frequency of tubercu-
losis in these patients. It is remarkable how good 
pulmonary function is in these men with limited 
chest expansion. A recent study indicates that im-
pairment of lung function is minimal in most of the 
patients with this disease ( 5). 
The variants of ankylosing spondylitis are shown 
in Table 3. All of these conditions can show sacro-
iliitis and indeed in some cases, go on to more exten-
sive spinal involvement quite similar to those seen in 
ankylosing spondylitis. I will mention some of these 
again later because of an interesting relationship. 
For many years, it has been felt that there were 
strong genetic features connected with ankylosing 
spondylitis. Several years ago, when I was still in 
Dallas, Morris Ziff and I, seeing our patients at 
the Veterans Administration Hospital, were struck 
by the relative rarity of ankylosing spondylitis among 
our black patients. (One of the earliest clinicians 
to note this rarity was Elam Toone in 1949.) 
He found, in a group of patients that he was 
studying in the McGuire Veterans Administration 
Hospital in Richmond, 26 white and only three 
black patients with ankylosing spondylitis ( 6). Table 
4 shows what we found in Dallas at the Veterans 
Hospital when we looked at the frequency of anky-
losing spondylitis in relation to a number of other 
disease admissions rates and the male population of 
Dallas ( 7). As you can see, although the admission 
rate to the Veterans Hospital clearly reflected the 
racial distribution of the population, there was a 
marked discrepancy in the relative ratio of patients 
TABLE 2 
COMPLICATION~ OF ANKYLOSING SPONDYLITIS 
Iritis 
Aortic Insufficiency (Aortitis) 
Heart Block (Myocarditis) 
Amyloidosis 
Atlantoaxial Subluxation 
Cauda Equina Involvement 
Upper Lobe Fibrosis 
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with ankylosing spondylitis. We were not satisfied 
with this view, thinking perhaps we might have an 
unusual situation. When data were pooled from a 
number of VA hospitals, we found a fourfold dif-
ference in the frequency of ankylosing spondylitis 
between whites and blacks. A search of the African 
literature showed that there are virtually no patients 
with ankylosing spondylitis in Africa among the 
black native population. A review of genetic studies 
in the United States indicated that the black popula-
tion of the United States has a 20-25% admixture 
of white genes. This admixture of white genes would 
very nicely account for the fact that ankylosing 
spondylitis was only found in about 20-25% of 
the expected frequency, if it had the same distribu-
tion in the blacks as it did in whites. 
This information was subsequently utilized by 
Schlosstein, Terasaki, Blues tone, and Pearson ( 8) 
at the Wadsworth VA Hospital in Los Angeles. 
The transplantation antigen known as W-27 was 
found in 8% of a caucasian population but was 
found in 88% of a group of patients with ankylosing 
spondylitis. It was also interesting to note that W-27 
is not found in Black Africans and is present in an 
approximate frequency of 4% in Black Americans. 
To further support the relationship of this antigen to 
ankylosing spondylitis, W-27 was found in eight of 
ten Black Americans with ankylosing spondylitis. 
Another and perhaps more striking correlary of 
TABLE 3 
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TABLE4 
RACIAL DISTRIBUTION OF ADMISSIONS AND OF ANKYLOSING SPONDYLITIS, RHEUMATOID ARTHRITIS, AND REITER'S SYNDROME AT 
DALLAS VETERANS ADMINISTRATION HOSPITAL 
Number White 
Males-Dallas, Texas (1960 census) 263,354 
Male Admissions (10 months, 1966) 5 , 182 
Ankylosing Spondylitis (1959- 1966) 41 
Rheumatoid Arthritis (1959- 1966) 90 
Reiter's Syndrome (1959- 1966) 7 
this data was recently presented by Rodney Blue-
stone of this group at the XIIIth International Con-
gress of Rheumatology in Kyoto, Japan (9). In 
Table 5 are seen their most recent data. As you can 
see, W-27 is found in 14 of 156 patients with 
psoriasis alone. This is just about the frequency found 
in the normal population; however, in those patients 
with psoriasis who develop spondylitis it has been 
found in four of six individuals. In patients with 
colitis who developed spondylitis, this high frequency 
was again found. Perhaps even more remarkable are 
15 out of 16 juvenile rheumatoid arthritics with W-27 
who had spondylitis. Chronic Reiter's syndrome had 
the W-27 antigen in every case. Perhaps more 
astonishing were the studies they subsequently did 
looking at patients with acute Reiter's syndrome. 
Even those who do not have spondylitis showed 
W-27 in a remarkably high frequency. 
We now seem to have a new tool for the diag-
nosis of some forms of arthritis. For example, in 
male children who develop what appears to be 
juvenile rheumatoid arthritis, looking for W-27 might 
give us a strong clue as to the future course of their 
disease. A similar use could be in suspected Reiter's 
syndrome. This has certainly opened the door to a 
most fascinating series of studies and conjectures 
TABLE 5 
Psoriasis with Spondylitis 
Psoriasis Alone 
Colitis with Spondylitis 
JRA with Spondylitis 
Chronic Reiter's with Spondylitis 







8 / 8 
22/ 23 
% % White-Black 
Number Black White Black Ratio 
61, 911 81 19 4.2 
1, 227 81 19 4 .2 
3 93 7 13 . 7 
16 85 15 5.6 
4 I. 8 
about the relationship of the W-27 antigen and 
spondylitis. 
In the treatment of ankylosing spondylitis, 
radiation therapy was at an early date, found to be 
effective for relief of pain; it's use was given up 
because of a reported high frequency of blood 
dyscrasias following its application. There are still 
some authors who feel that its limited use in patients 
who are having pain in spite of other therapy is of 
distinct benefit and of low risk ( 10). Indomethacin 
and phenylbutazone are the most frequently used 
drugs in the treatment of this disease. An observa-
tion was made recently that a patient with severe 
ankylosing spondylitis who did not respond to the 
above mentioned drugs responded quite well to 
penicillamine therapy ( 11). Steroids are of little 
use in this group of patients. Teaching the patients 
exercises in an attempt to increase diaphragmatic 
breathing is of benefit and exercises may sometimes 
help to maintain the spine in better position. 
It is worth noting that what we have learned 
about this disease in recent years has provided us 
with better methods of establishing the diagnosis and 
prognosis of ankylosing spondylitis. 
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